EORTC Data Center, Brussels
Bacillus Calmette-Guerin compared against chemotherapy for bladder cancer
Published in Pharma Law Weekly, August 16th, 2005
"We determined the short-term and long-term efficacy of BCG and chemotherapy in the treatment of patients with carcinoma in situ (CIS). A meta-analysis was performed on published results of randomized clinical trials comparing intravesical BCG to intravesical chemotherapy. Nine randomized trials including 700 patients with CIS compared BCG to either mitomycin C (MMC), epirubicin, adriamycin, or sequential MMC/adriamycin," scientists writing in the Journal of Urology reported.
"Of 298 patients on BCG, 203 (68.1%) had a complete...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2005-08-16)
More Articles from Pharma Law Weekly
- AlphaRx, Inc.
Antibiotic development program uses nanoparticle delivery platform - Amrad
U.S. patent granted for asthma treatment - Bristol-Myers Squibb Company
Agreement signed for sale of U.S., Canadian consumer medicines business - Cardinal Health, Inc.
Prescription drug benefit is on the way for patients with limited income - Consumers Union
Voluntary advertising plan won't cut it, consumer group says - Dey, LP
Pharma company reaches settlement with Connecticut on pricing litigation - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
